ziprasidone has been researched along with Neuroleptic Malignant Syndrome in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (76.92) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Alexander, KM; Caposole, MZ; Ficarino, HM; Kinnard, CM; McGowin, EF; N Krebsbach, M; Noelle Davis, S; Simmons, JD | 1 |
| Atreya, A; Basnyat, S; Phuyal, P; Pokhrel, S; Sedhai, YR | 1 |
| Croarkin, PE; Emslie, GJ; Mayes, TL | 1 |
| Conley, Y; Davies, MA; Roth, BL | 1 |
| McNeely, MJ; Yang, SH | 1 |
| Chacko, RC; Mistry, SG; Murty, RG | 1 |
| Gray, NS | 1 |
| Hasan, RA; Leibold, J; Patel, V | 1 |
| Bond, LC; Borovicka, MC; Gaughan, KM | 1 |
| Keck, PE; Strawn, JR | 1 |
| Coffey, B; Jummani, R; Vito, J | 1 |
| Cansel, N; Herken, H; Ozen, ME; Savas, HA; Yumru, M | 1 |
| Aukst-Margetic, B; Margetic, B | 1 |
1 review(s) available for ziprasidone and Neuroleptic Malignant Syndrome
| Article | Year |
|---|---|
Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Child; Child, Preschool; Clozapine; Dibenzothiazepines; Humans; Neuroleptic Malignant Syndrome; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Thiazoles | 2008 |
12 other study(ies) available for ziprasidone and Neuroleptic Malignant Syndrome
| Article | Year |
|---|---|
Neuroleptic Malignant Syndrome: A Potential Etiology of Multisystem Organ Failure in a Burn Patient.
Topics: Accidents, Occupational; Acute Coronary Syndrome; Adult; Antipsychotic Agents; Bipolar Disorder; Body Surface Area; Burns, Chemical; Calcium; Creatine Kinase; Humans; Hypocalcemia; Male; Multiple Organ Failure; Neuroleptic Malignant Syndrome; Piperazines; Tachycardia, Ventricular; Thiazoles; Troponin | 2022 |
Case Report: Ziprasidone induced neuroleptic malignant syndrome.
Topics: Antipsychotic Agents; Humans; Neuroleptic Malignant Syndrome; Piperazines; Thiazoles | 2021 |
Functional SNPs in genes encoding the 5-HT2A receptor modify the affinity and potency of several atypical antipsychotic drugs.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Drug Resistance; HEK293 Cells; Humans; Mutagenesis, Site-Directed; Neuroleptic Malignant Syndrome; Nursing Research; Olanzapine; Pharmacogenetics; Piperazines; Polymorphism, Single Nucleotide; Quetiapine Fumarate; Quinolones; Receptor, Serotonin, 5-HT2A; Risperidone; Thiazoles | 2011 |
Rhabdomyolysis, pancreatitis, and hyperglycemia with ziprasidone.
Topics: Antipsychotic Agents; Diabetes Mellitus, Type 2; Diagnosis, Differential; Female; Fever; Humans; Hyperglycemia; Middle Aged; Muscle Rigidity; Neuroleptic Malignant Syndrome; Pancreatitis; Piperazines; Psychotic Disorders; Rhabdomyolysis; Thiazoles | 2002 |
Neuroleptic Malignant Syndrome with ziprasidone.
Topics: Affective Disorders, Psychotic; Antipsychotic Agents; Dopamine Antagonists; Female; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Piperazines; Serotonin Antagonists; Thiazoles | 2002 |
Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: a diagnostic challenge.
Topics: Antipsychotic Agents; Female; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Piperazines; Thiazoles | 2004 |
Neuroleptic malignant syndrome associated with ziprasidone in an adolescent.
Topics: Adolescent; Antipsychotic Agents; Humans; Male; Neuroleptic Malignant Syndrome; Piperazines; Psychotic Disorders; Thiazoles | 2004 |
Ziprasidone- and lithium-induced neuroleptic malignant syndrome.
Topics: Antipsychotic Agents; Humans; Hypotension; Lithium; Male; Middle Aged; Neuroleptic Malignant Syndrome; Piperazines; Psychotic Disorders; Thiazoles | 2006 |
Early bicarbonate loading and dantroline for ziprasidone/haloperidol-induced neuroleptic malignant syndrome.
Topics: Adolescent; Antipsychotic Agents; Autistic Disorder; Combined Modality Therapy; Dantrolene; Disruptive, Impulse Control, and Conduct Disorders; Drug Administration Schedule; Fluid Therapy; Haloperidol; Humans; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Piperazines; Self-Injurious Behavior; Sodium Bicarbonate; Thiazoles | 2006 |
Advanced pediatric psychopharmacology.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Cannabinoids; Combined Modality Therapy; Comorbidity; Drug Therapy, Combination; Humans; Male; Marijuana Abuse; Mental Status Schedule; Neuroleptic Malignant Syndrome; Patient Readmission; Piperazines; Prognosis; Psychoses, Substance-Induced; Quinolones; Recurrence; Social Environment; Thiazoles; Treatment Refusal | 2006 |
Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
Topics: Adult; Antipsychotic Agents; Biperiden; Diagnosis, Differential; Diazepam; Drug Therapy, Combination; Humans; Infusions, Intravenous; Male; Neuroleptic Malignant Syndrome; Neurologic Examination; Parkinsonian Disorders; Piperazines; Schizophrenia; Thiazoles | 2007 |
Comments on the report of neuroleptic malignant syndrome induced by ziprasidone.
Topics: Antipsychotic Agents; Benzodiazepines; Diagnosis, Differential; Humans; Male; Neuroleptic Malignant Syndrome; Olanzapine; Patient Compliance; Patient Discharge; Piperazines; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome | 2007 |